NCT02563327 Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis Status COMPLETED Phase PHASE3
NCT02538952 Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons Status COMPLETED Phase PHASE4
NCT02534727 Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance Status COMPLETED Phase N/A
NCT02533089 Training Lay Healthcare Workers to Optimize TB Care and Improve Outcomes in Malawi Status COMPLETED Phase NA
NCT02532036 MVA85A Aerosol vs Intramuscular Vaccination in Adults With Latent Mycobacterium Tuberculosis (M. tb) Infection Status TERMINATED Phase PHASE1
NCT02512939 Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection Status COMPLETED Phase NA
NCT02508376 Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT02503839 Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic Status COMPLETED Phase PHASE1
NCT02501421 Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine Status COMPLETED Phase PHASE1
NCT02497079 Diagnostic Accuracy of Polymerase Chain Reaction for Mycobacterium Tuberculosis Using EBUS-TBNA Samples Status UNKNOWN Phase NA
NCT02454205 An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis Status COMPLETED Phase PHASE2/PHASE3
NCT02430506 A Study to Evaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QFT (+) and (-) Adults Without Evidence of TB Status COMPLETED Phase PHASE1
NCT02430259 Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention Status COMPLETED Phase PHASE3